title: Diffusion-perfusion mismatch: an opportunity for improvement in cortical function.
abstract: OBJECTIVE
  There has been controversy over whether diffusion-perfusion mismatch provides a biomarker for the ischemic penumbra. In the context of clinical stroke trials, regions of the diffusion-perfusion mismatch that do not progress to infarct in the absence of reperfusion are considered to represent "benign oligemia." However, at least in some cases (particularly large vessel stenosis), some of this hypoperfused tissue may remain dysfunctional for a prolonged period without progressing to infarct and may recover function if eventually reperfused. We hypothesized that patients with persistent diffusion-perfusion mismatch using a hypoperfusion threshold of 4-5.9 s delay on time-to-peak (TTP) maps at least sometimes have persistent cognitive deficits relative to those who show some reperfusion of this hypoperfused tissue.
  
  
  METHODS
  We tested this hypothesis in 38 patients with acute ischemic stroke who had simple cognitive tests (naming or line cancelation) and MRI with diffusion and perfusion imaging within 24 h of onset and again within 10 days, most of whom had large vessel stenosis or occlusion.
  
  
  RESULTS
  A persistent perfusion deficit of 4-5.9 s delay in TTP on follow up MRI was associated with a persistent cognitive deficit at that time point (p < 0.001). When we evaluated only patients who did not have infarct growth (n = 14), persistent hypoperfusion (persistent mismatch) was associated with a lack of cognitive improvement compared with those who had reperfused. The initial volume of hypoperfusion did not correlate with the later infarct volume (progression to infarct), but change in volume of hypoperfusion correlated with change in cognitive performance (p = 0.0001). Moreover, multivariable regression showed that the change in volume of hypoperfused tissue of 4-5.9 s delay (p = 0.002), and change in volume of ischemic tissue on diffusion weighted imaging (p = 0.02) were independently associated with change in cognitive function.
  
  
  CONCLUSIONS
  Our results provide additional evidence that non-infarcted tissue with a TTP delay of 4-5.9 s may be associated with persistent deficits, even if it does not always result in imminent progression to infarct. This tissue may represent the occasional opportunity to intervene to improve function even days after onset of symptoms.
authors: R Adams Shock Trauma Center, University of Maryland School of Medicine , Baltimore, MD , USA.
authors: Melissa
authors: M
authors: Motta
authors: Johns Hopkins University School of Medicine , Baltimore, MD , USA.
authors: Amanda
authors: A
authors: Ramadan
authors: Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD , USA.
authors: Argye E
authors: AE
authors: Hillis
authors: Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD , USA.
authors: Rebecca F
authors: RF
authors: Gottesman
authors: Department of Neurology, Johns Hopkins University School of Medicine , Baltimore, MD , USA.
authors: Richard
authors: R
authors: Leigh
keywords: NIHSS; acute ischemic stroke; diffusion–perfusion mismatch; functional outcome; penumbra
references: Stroke. 2009 Feb;40(2):469-75
references: 19109547
references: Stroke. 2003 Oct;34(10):2392-6
references: 12958320
references: Ann Neurol. 1996 Aug;40(2):216-26
references: 8773603
references: Stroke. 2013 Jan;44(1):87-93
references: 23250996
references: Brain. 2011 Jun;134(Pt 6):1765-76
references: 21616971
references: Stroke. 1981 Nov-Dec;12(6):723-5
references: 6272455
references: Lancet Neurol. 2006 Sep;5(9):755-68
references: 16914404
references: Brain. 2002 May;125(Pt 5):1094-104
references: 11960898
references: Stroke. 1977 Jan-Feb;8(1):51-7
references: 13521
references: Stroke. 2005 May;36(5):980-5
references: 15790950
references: Neurology. 1999 Oct 22;53(7):1528-37
references: 10534263
references: Stroke. 2003 Nov;34(11):2729-35
references: 14576370
references: Ann Neurol. 2002 Apr;51(4):417-32
references: 11921048
references: Stroke. 2010 Dec;41(12 ):2817-21
references: 21030699
references: J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):334-9
references: 16239323
references: Stroke. 2009 Jun;40(6):2055-61
references: 19359626
references: Lancet Neurol. 2012 Oct;11(10):860-7
references: 22954705
references: Stroke. 1981 Jul-Aug;12(4):454-9
references: 6976022
references: Stroke. 2008 Mar;39(3):870-7
references: 18258831
references: Brain. 2004 Jun;127(Pt 6):1427-36
references: 15130953